RCMI Coordinating Center (RCMI CC) Header Logo

Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.

Col?n JM, Miranda JD. Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery. Neural Regen Res. 2016 Aug; 11(8):1208-11.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support